We are live on ! Find out more
HC

Henshaw Capital Portfolio holdings

AUM $2.7B
1-Year Est. Return 29.67%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+29.67%
3 Year Est. Return
+102.72%
5 Year Est. Return
+136.36%
10 Year Est. Return
+453.01%
AUM
$1.27B
AUM Growth
+$91.4M
Cap. Flow
+$11.7M
Cap. Flow %
0.92%
Top 10 Hldgs %
36.41%
Holding
314
New
30
Increased
89
Reduced
48
Closed
41

Sector Composition

Rank Sector Weight
1 Technology 21.1%
2 Industrials 16.81%
3 Communication Services 12.47%
4 Financials 11.71%
5 Healthcare 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
226
Sherwin-Williams
SHW
$87.4B
$256K 0.02%
1,314
-390
-23% -$74.4K
BHP icon
227
BHP
BHP
$213B
$254K 0.02%
5,210
RPT
228
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$253K 0.02%
16,830
-2,826
-14% -$40.4K
ESE icon
229
ESCO Technologies
ESE
$8.18B
$250K 0.02%
2,705
CMCO icon
230
Columbus McKinnon
CMCO
$467M
$250K 0.02%
6,248
KALU icon
231
Kaiser Aluminum
KALU
$2.65B
$249K 0.02%
2,245
FSV icon
232
FirstService
FSV
$6.58B
$249K 0.02%
+2,674
New +$252K
SMTC icon
233
Semtech
SMTC
$10.4B
$248K 0.02%
4,695
CSFL
234
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$248K 0.02%
9,915
+1,175
+13% +$29.4K
PBH icon
235
Prestige Consumer Healthcare
PBH
$2.45B
$246K 0.02%
6,069
WMGI
236
DELISTED
Wright Medical Group Inc
WMGI
$242K 0.02%
7,954
-1,833
-19% -$48K
ONB icon
237
Old National Bancorp
ONB
$10.3B
$242K 0.02%
13,244
MOMO
238
Hello Group
MOMO
$869M
$240K 0.02%
7,171
ONC
239
BeOne Medicines Ltd
ONC
$34.3B
$237K 0.02%
+1,430
New +$238K
GSK icon
240
GSK
GSK
$108B
$236K 0.02%
4,018
-4,579
-53% -$255K
FFBC icon
241
First Financial Bancorp
FFBC
$3.55B
$235K 0.02%
9,237
AIT icon
242
Applied Industrial Technologies
AIT
$12.9B
$233K 0.02%
+3,496
New +$214K
TDOC icon
243
Teladoc Health
TDOC
$1.69B
$231K 0.02%
+2,761
New +$210K
IBTX
244
DELISTED
Independent Bank Group, Inc.
IBTX
$230K 0.02%
+4,145
New +$230K
AZTA icon
245
Azenta
AZTA
$1.33B
$228K 0.02%
5,423
-1,112
-17% -$46.7K
ICPT
246
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$227K 0.02%
+1,829
New +$164K
ABBV icon
247
AbbVie
ABBV
$465B
$226K 0.02%
+2,550
New +$212K
EFOR
248
Everforth Inc
EFOR
$953M
$225K 0.02%
+3,170
New +$207K
NFLX icon
249
Netflix
NFLX
$301B
$224K 0.02%
6,910
-2,340
-25% -$69.4K
NTRA icon
250
Natera
NTRA
$36.1B
$222K 0.02%
6,598
-671
-9% -$24.7K

Similar funds

Henshaw Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Henshaw Capital held 314 positions worth $1.27B, up 7.7% from $1.18B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Henshaw Capital's Q4 2019 filing shows 30 new, 89 increased, 48 reduced and 41 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 296,910 shares worth $16M. The largest sale was ExxonMobil, an estimated $13.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Communication Services.

  • Henshaw Capital's largest Q4 2019 buy was iShares Core MSCI Emerging Markets ETF: 296,910 shares worth $16M.
  • Henshaw Capital added most to Chevron in Q4 2019, an estimated $13.3M increase.
  • Henshaw Capital's biggest Q4 2019 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $10.8M.
  • Henshaw Capital fully exited ExxonMobil in Q4 2019, selling an estimated $13.6M.
  • Henshaw Capital's ten largest holdings make up 36% of its $1.27B portfolio in Q4 2019.
  • Henshaw Capital opened 30 new positions and closed 41 in Q4 2019.
  • Henshaw Capital's portfolio value rose 7.7% quarter-over-quarter to $1.27B.

Based on Henshaw Capital's 13F filing for Q4 2019, filed 28 May 2026.